Novo Nordisk A/S
 
Search
 Search

Novo Nordisk Launches the Novo Nordisk BlueSheet Q1 2012 - Expert Q&A with Matthias von Herrath, MD

According to recent reports, the  incidence of type 1 diabetes has been increasing throughout  the globe at rates ranging from 3 to 5 percent a year as researchers struggle to determine a cause.1
We asked Dr. Matthias von Herrath, the head of Novo Nordisk’s new diabetes research center in Seattle, to share his thoughts on the rise in type 1 diabetes and the biggest challenges in researching the disease.

< |> || > 1 2 3 4 5

Online News
Loading...

 Print    Email